Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| plasma cell | 9 studies | 27% ± 10% | |
| GABAergic neuron | 5 studies | 32% ± 13% | |
| glutamatergic neuron | 5 studies | 33% ± 15% | |
| neuron | 4 studies | 23% ± 4% | |
| endothelial cell | 4 studies | 18% ± 1% | |
| plasmablast | 3 studies | 43% ± 18% | |
| pancreatic A cell | 3 studies | 21% ± 1% | |
| interneuron | 3 studies | 35% ± 12% | |
| oligodendrocyte precursor cell | 3 studies | 23% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 26% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2382.58 | 2639 / 2642 | 100% | 76.16 | 704 / 705 |
| lung | 99% | 1609.12 | 575 / 578 | 99% | 35.70 | 1149 / 1155 |
| breast | 100% | 1209.65 | 459 / 459 | 99% | 43.55 | 1104 / 1118 |
| prostate | 100% | 1127.17 | 244 / 245 | 98% | 32.10 | 491 / 502 |
| thymus | 100% | 1172.18 | 651 / 653 | 97% | 27.25 | 588 / 605 |
| ovary | 100% | 1561.35 | 180 / 180 | 97% | 22.58 | 416 / 430 |
| esophagus | 98% | 871.83 | 1409 / 1445 | 99% | 29.18 | 181 / 183 |
| adrenal gland | 100% | 1694.10 | 258 / 258 | 96% | 66.70 | 221 / 230 |
| uterus | 100% | 1661.76 | 170 / 170 | 95% | 28.58 | 438 / 459 |
| stomach | 99% | 891.91 | 356 / 359 | 96% | 23.60 | 275 / 286 |
| kidney | 99% | 958.98 | 88 / 89 | 96% | 38.85 | 867 / 901 |
| intestine | 100% | 1089.98 | 965 / 966 | 94% | 23.31 | 498 / 527 |
| pancreas | 99% | 979.48 | 324 / 328 | 96% | 23.59 | 170 / 178 |
| bladder | 100% | 1202.43 | 21 / 21 | 92% | 23.79 | 466 / 504 |
| skin | 89% | 1525.64 | 1606 / 1809 | 93% | 44.65 | 440 / 472 |
| liver | 89% | 989.97 | 201 / 226 | 81% | 14.52 | 328 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 26.65 | 45 / 45 |
| blood vessel | 100% | 1856.27 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 1383.16 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1258.59 | 240 / 241 | 0% | 0 | 0 / 0 |
| heart | 93% | 953.33 | 804 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 19.34 | 27 / 29 |
| peripheral blood | 64% | 1011.53 | 599 / 929 | 0% | 0 | 0 / 0 |
| muscle | 62% | 303.09 | 495 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 61% | 10.29 | 49 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051085 | Biological process | chaperone cofactor-dependent protein refolding |
| GO_0042026 | Biological process | protein refolding |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0044183 | Molecular function | protein folding chaperone |
| GO_0031072 | Molecular function | heat shock protein binding |
| GO_0140662 | Molecular function | ATP-dependent protein folding chaperone |
| GO_0005515 | Molecular function | protein binding |
| GO_0016887 | Molecular function | ATP hydrolysis activity |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | HSPA13 |
| Protein name | Heat shock 70 kDa protein 13 (Microsomal stress-70 protein ATPase core) (Stress-70 protein chaperone microsome-associated 60 kDa protein) |
| Synonyms | STCH |
| Description | FUNCTION: Has peptide-independent ATPase activity. |
| Accessions | P48723 ENST00000285667.4 |